Contribution of Stent Underexpansion to Recurrence after Sirolimus-Eluting Stent Implantation for In-Stent Restenosis

Circulation

Volumn 109, Issue 9, 2004, Pages 1085-1088

  Fujii, Kenichi ^a   Mintz, Gary S ^a   Kobayashi, Yoshio ^a   Carlier, Stéphane G ^a   Takebayashi, Hideo ^a   Yasuda, Takenori ^a   Moussa, Issam ^a   Dangas, George ^a   Mehran, Roxana ^a   Lansky, Alexandra J ^a   Reyes, Arlene ^a   Kreps, Edward ^a   Collins, Michael ^a   Colombo, Antonio ^a   Stone, Gregg W ^a   Teirstein, Paul S ^a   Leon, Martin B ^a   Moses, Jeffrey W ^a,b  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Restenosis; Stents; Ultrasonics

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMPLANTATION; IN STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; STENT; TREATMENT FAILURE; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; SIROLIMUS; STENTS; TREATMENT FAILURE;

EID: 12144286893     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000121327.67756.19     Document Type: Article

References (11)

1. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496-501.
2. Bauters C, Banos JL, Van Belle E, et al. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation. 1998;97:318-321.
3. Burke SE, Lubbers NL, Chen YW, et al. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J Cardiovasc Pharmacol. 1999;33:829-835.
4. Morice MC, Serruys PW, Sousa JE, et al. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
5. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
6. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol. 2003;41:184-189.
7. Saia F, Lemos PA, Sianos G, et al. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol. 2003;92:200-203.
8. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-1878.
9. Lemos PA, Saia F, Ligthart JM, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003;108:257-260.
10. Sonoda S, Morino Y, Ako J, et al. An optimal diagnostic threshold of minimum stent area to predict long-term stent patency following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS Trial. J Am Coll Cardiol. 2003;41:80A.
11. Painter JA, Mintz GS, Wong SC, et al. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol. 1995;75:398-400.